<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl1" position="float"><object-id pub-id-type="doi">10.7554/eLife.15175.004</object-id><label>Table 1.</label><caption><p>Detection of tumor-specific mutations in cyst fluid. The fraction of samples detected and the median fraction of mutant alleles are indicated, grouped by cyst type, cancer stage, and the need for surgery.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.15175.004">http://dx.doi.org/10.7554/eLife.15175.004</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom"/><th valign="bottom">Fraction of samples detected (95% confidence interval)</th><th valign="bottom">Median fraction of mutant alleles (IQR)</th><th valign="bottom">Total # of samples</th></tr></thead><tbody><tr><td valign="bottom"><italic>Type</italic></td><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/></tr><tr><td valign="bottom">Non-neoplastic</td><td valign="bottom">0% (0&#8211;46%)</td><td valign="bottom">0% (0&#8211;0%)</td><td valign="bottom">6</td></tr><tr><td valign="bottom">Benign tumor</td><td valign="bottom">0% (0&#8211;26%)</td><td valign="bottom">0% (0&#8211;0%)</td><td valign="bottom">12</td></tr><tr><td valign="bottom">Borderline tumor</td><td valign="bottom">83% (61&#8211;95%)</td><td valign="bottom">2.4% (1.5&#8211;10.8%)</td><td valign="bottom">23</td></tr><tr><td valign="bottom">Type I cancer</td><td valign="bottom">77% (46&#8211;95%)</td><td valign="bottom">7.8% (3.3&#8211;28.7%)</td><td valign="bottom">13</td></tr><tr><td valign="bottom">Type II cancer</td><td valign="bottom">100% (81&#8211;100%)</td><td valign="bottom">60.3% (31.3&#8211;70.8%)</td><td valign="bottom">18</td></tr><tr><td valign="bottom"><italic>Cancer stage</italic></td><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/></tr><tr><td valign="bottom">Early (I and II)</td><td valign="bottom">82% (48&#8211;97%)</td><td valign="bottom">7.4% (3.0&#8211;30.9%)</td><td valign="bottom">11</td></tr><tr><td valign="bottom">Late (III and IV)</td><td valign="bottom">95% (75&#8211;100%)</td><td valign="bottom">51.2% (30.2&#8211;69.5%)</td><td valign="bottom">20</td></tr><tr><td valign="bottom"><italic>Cysts requiring surgery</italic></td><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/></tr><tr><td valign="bottom">No</td><td valign="bottom">0% (0&#8211;26%)</td><td valign="bottom">0% (0&#8211;0%)</td><td valign="bottom">18</td></tr><tr><td valign="bottom">Yes</td><td valign="bottom">87% (75&#8211;95%)</td><td valign="bottom">12.6% (2.7&#8211;40.2%)</td><td valign="bottom">54</td></tr></tbody></table></table-wrap>